Does daily fasting shielding kidney on hyperglycemia-related inflammatory cytokine via TNF-α, NLRP3, TGF-β1 and VCAM-1 mRNA expression

ArticleAçık Erişim

Özet

This study aimed to investigate the effects of blood glucose control and the kidneys' functions, depending on fasting, in the streptozotocin-induced diabetes model in rats via TNF-α, NLRP-3, TGF-β1 and VCAM-1 mRNA expression in the present study. 32 Wistar albino rats were allocated randomly into four main groups; H (Healthy, n = 6), HF (Healthy fasting, n = 6), D (Diabetes, n = 10), DF (Diabetes and fasting, n = 10). Blood glucose and HbA1c levels significantly increased in the D group compared to the healthy ones (p < 0.05). However, the fasting period significantly improved blood glucose and HbA1c levels 14 days after STZ induced diabetes in rats compared to the D group. Similar findings we obtained for serum (BUN-creatinine) and urine samples (creatinine and urea levels). STZ induced high glucose levels significantly up-regulated TNF-α, NLRP-3, TGF-β1 and VCAM-1 mRNA expression and fasting significantly decreased these parameters when compared to diabetic rats. Histopathological staining also demonstrated the protective effects of fasting on diabetic kidney tissue. In conclusion, intermittent fasting regulated blood glucose level as well as decreasing harmful effects of diabetes on kidney tissue. The fasting period significantly decreased the hyperglycemia-related inflammatory cytokine damage on kidneys and also reduced apoptosis in favor of living organisms. © 2021 Elsevier B.V.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/13375Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorBilen, Arzu
dc.contributor.authorCalik, Ilknur
dc.contributor.authorYayla, Muhammed
dc.contributor.authorDincer, Busra
dc.contributor.authorTavaci, Taha
dc.contributor.authorCinar, Irfan
dc.contributor.authorBilen, Habip
dc.contributor.authorCadirci, Elif
dc.contributor.authorHalici, Zekai
dc.contributor.authorMercantepe, Filiz
dc.date.accessioned2026-10-18T20:28:12.875400133Z
dc.date.available2026-10-18T20:28:12.875400133Z
dc.date.issued2021
dc.description.abstractThis study aimed to investigate the effects of blood glucose control and the kidneys' functions, depending on fasting, in the streptozotocin-induced diabetes model in rats via TNF-α, NLRP-3, TGF-β1 and VCAM-1 mRNA expression in the present study. 32 Wistar albino rats were allocated randomly into four main groups; H (Healthy, n = 6), HF (Healthy fasting, n = 6), D (Diabetes, n = 10), DF (Diabetes and fasting, n = 10). Blood glucose and HbA1c levels significantly increased in the D group compared to the healthy ones (p < 0.05). However, the fasting period significantly improved blood glucose and HbA1c levels 14 days after STZ induced diabetes in rats compared to the D group. Similar findings we obtained for serum (BUN-creatinine) and urine samples (creatinine and urea levels). STZ induced high glucose levels significantly up-regulated TNF-α, NLRP-3, TGF-β1 and VCAM-1 mRNA expression and fasting significantly decreased these parameters when compared to diabetic rats. Histopathological staining also demonstrated the protective effects of fasting on diabetic kidney tissue. In conclusion, intermittent fasting regulated blood glucose level as well as decreasing harmful effects of diabetes on kidney tissue. The fasting period significantly decreased the hyperglycemia-related inflammatory cytokine damage on kidneys and also reduced apoptosis in favor of living organisms. © 2021 Elsevier B.V.
dc.identifier.doi10.1016/j.ijbiomac.2021.08.216
dc.identifier.eissn1879-0003
dc.identifier.endpage918
dc.identifier.issn0141-8130
dc.identifier.pmid34492249
dc.identifier.scopus2-s2.0-85114951808
dc.identifier.startpage911
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/13375
dc.identifier.volume190
dc.identifier.wosWOS:000710167500003
dc.language.isoen
dc.publisherElsevier B.V.
dc.relation.ispartofInternational Journal of Biological Macromolecules
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectDiabetes
dc.subjectFasting
dc.subjectKidney
dc.subjectRat
dc.subjectAnimals
dc.subjectApoptosis
dc.subjectBlood Glucose
dc.subjectBlood Urea Nitrogen
dc.subjectCaspase 9
dc.subjectCreatinine
dc.subjectDiabetes Mellitus, Experimental
dc.subjectGlycated Hemoglobin A
dc.subjectHyperglycemia
dc.subjectInflammation
dc.subjectNLR Family, Pyrin Domain-Containing 3 Protein
dc.subjectRats, Wistar
dc.subjectRNA, Messenger
dc.subjectTransforming Growth Factor beta1
dc.subjectTumor Necrosis Factor-alpha
dc.subjectUrea
dc.subjectVascular Cell Adhesion Molecule-1
dc.subjectcryopyrin
dc.subjectglucose
dc.subjecthemoglobin A1c
dc.subjectmessenger RNA
dc.subjecttumor necrosis factor
dc.subjectvascular cell adhesion molecule 1
dc.subjectglycosylated hemoglobin
dc.subjectanimal experiment
dc.subjectanimal model
dc.titleDoes daily fasting shielding kidney on hyperglycemia-related inflammatory cytokine via TNF-α, NLRP3, TGF-β1 and VCAM-1 mRNA expression
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus21
rdl.citation.wos20
rdl.departmentDepartment of Pharmacology, Faculty of Pharmacy, Erzincan Binali Yildirim University, Erzincan, Turkey.
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)